CW // S P O I L E R (Jaga-jaga)

S1egfr1ed mulai dewasa episode berapa? Udah muncul apa belum, soalnya aku masih sampai tengah.

Gepeng Th3 H3r0 is St4nding 1n My W4y

0 8

CHERNEY: Characteristics of participants enrolled in renal outcome trials involving SGLT2 inhibitors

EMPA-KIDNEY ⏳⌛️
🔲 +/- Type 2 DM (T2D)
🔲 eGFR ~ 20
🔲 Low levels of albuminuria
🇲🇾

👉 https://t.co/R8rVmrqwAf

20 35

CHERNEY: Characteristics of participants enrolled in renal outcome trials involving SGLT2 inhibitors

EMPA-KIDNEY (still ongoing)
🔲 +/- Type 2 Diabetes
🔲 eGFR ~ 20
🔲 Low levels of albuminuria


https://t.co/VEBssUX9pV

4 5

Happy to report our study on mutations/amplification in metastatic KRAS amplification likely confers resistance to anti-EGFR therapy. An excellent collaboration between https://t.co/5UztaMBBOT

27 60

From the February issue: Histone lysine methylation dynamics control DNA copy number amplification https://t.co/CWjdp6PPpR

9 13

The combination of BRAF mutations and low EGFR expression makes patients with colon neuroendocrine carcinomas good candidates for clinical BRAF inhibition. https://t.co/JUEwLRRfOr

3 7

Exploring EGFR kinase domain mutants confer osimertinib resistance.
https://t.co/eDcwYqSnYO and https://t.co/NX2EZMO3O7 are of

0 5